Rapid conversion of effector mechanisms from NK to T cells during virus-induced lysis of allogeneic implants in vivo

Journal of Immunology

Volumn 174, Issue 11, 2005, Pages 6663-6671

  Brehm, Michael A ^a   Daniels, Keith A ^a   Ortaldo, John R ^b   Welsh, Raymond M ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE;

ALLOGRAFT; ANIMAL EXPERIMENT; ARTICLE; CELL ACTIVATION; CELL KILLING; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXICITY; EFFECTOR CELL; GRAFT REJECTION; HAPLOTYPE; IMMUNE RESPONSE; IN VIVO STUDY; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MALE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE; VIRUS INFECTION;

EID: 18944366601     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.174.11.6663     Document Type: Article

References (62)

1. Forman, D., R. M. Welsh, T. G. Markees, B. A. Woda, J. P. Mordes, A. A. Rossini, and D. L. Greiner. 2002. Viral abrogation of stem cell transplantation tolerance causes graft rejection and host death by different mechanisms. J. Immunol. 168: 6047-6056.
2. Gaston, J. S. H., and M. Waer. 1985. Virus-specific MHC-restricted T lymphocytes may initiate allograft rejection. Immunol. Today 6: 237-239.
3. Jakel, K. T., and T. Loning. 1993. Herpes virus infections, acute rejection, and transplant arteriosclerosis in human cardiac allografts. Transplant. Proc. 25: 2029-2030.
4. Welsh, R. M., T. G. Markees, B. A. Woda, K. A. Daniels, M. A. Brehm, J. P. Mordes, D. L. Greiner, and A. A. Rossini. 2000. Virus-induced abrogation of transplantation tolerance induced by donor-specific transfusion and anti-CD154 antibody. J. Virol. 74: 2210-2218.
5. Brehm, M. A., L. K. Selin, and R. M. Welsh. 2004. CD8 T cell responses to viral infections in sequence. Cell. Microbiol. 6: 411-421.
6. Burrows, S. R., R. Khanna, S. L. Silins, and D. J. Moss. 1999. The influence of antiviral T-Cell responses on the alloreactive repertoire. Immunol. Today 20: 203-207.
7. + T-cell deletion induced by costimulation blockade. J. Surg. Res. 93: 63-69.
8. Wood, K. J., and S. Sakaguchi. 2003. Regulatory T cells in transplantation tolerance. Nat. Rev. Immunol. 3: 199-210.
9. Nahill, S. R., and R. M. Welsh. 1993. High frequency of cross-reactive cytotoxic T lymphocytes elicited during the virus-induced polyclonal cytotoxic T lymphocyte response. J. Exp. Med. 177: 317-327.
10. Yang, H., and R. M. Welsh. 1986. Induction of alloreactive cytotoxic T cells by acute virus infection of mice. J. Immunol. 136: 1186-1193.
11. Cudkowicz, G., and M. Bennett. 1971. Peculiar immunobiology of bone marrow allografts. I. Graft rejection by irradiated responder mice. J. Exp. Med. 134: 83-102.
12. Rosenberg, A. S., T. Mizuochi, S. O. Sharrow, and A. Singer. 1987. Phenotype, specificity, and function of T cell subsets and T cell interactions involved in skin allograft rejection. J. Exp. Med. 165: 1296-1315.
13. Lanier, L. L. 1998. NK cell receptors. Annu. Rev. Immunol. 16: 359-393.
14. Backstrom, E., K. Kristensson, and H. G. Ljunggren. 2004. Activation of natural killer cells: underlying molecular mechanisms revealed. Scand. J. Immunol. 60: 14-22.
15. Golshayan, D., and R. Lechler. 2004. Commentary: priming of alloreactive T cells-where does it happen? Eur. J. Immunol. 34: 3301-3304.
16. Watschinger, B. 1995. How T cells recognize alloantigen: evidence for two pathways of allorecognition. Nephrol. Dial. Transplant. 10: 1556-1558.
17. Ford, W. L., S. I. Simmonds, and R. C. Atkikn. 1975. Early cellular events in a systemic graft-vs.-host reaction. II. Autoradiographic estimates of donor lymphocytes which response to Ag-B-determined antigenic complexes. J. Exp. Med. 141: 681-696.
18. Lindahl, K. F., and D. B. Wilson. 1977. Histocompatibility antigen-activated cytotoxic T lymphocytes. II. Estimates of the frequency and specificity of precursors. J. Exp. Med. 145: 508-522.
19. Suchin, E. J., P. B. Langmuir, E. Palmer, M. H. Sayegh, A. D. Wells, and L. A. Turka. 2001. Quantifying the frequency of alloreactive T cells in vivo: new answers to an old question. J. Immunol. 166: 973-981.
20. Welsh, R. M. 1978. Cytotoxic cells induced during lymphocytic choriomeningitis virus infection of mice. I. Characterization of natural killer cell induction. J. Exp. Med. 148: 163-181.
21. Guidotti, L. G., and F. V. Chisari. 2001. Noncytolytic control of viral infections by the innate and adaptive immune response. Annu. Rev. Immunol. 19: 65-91.
22. Biron, C. A. 1999. Initial and innate responses to viral infections: pattern setting in immunity or disease. Curr. Opin. Microbiol. 2: 374-381.
23. Biron, C. A., K. B. Nguyen, and G. C. Pien. 2002. Innate immune responses to LCMV infections: natural killer cells and cytokines. Curr. Top. Microbiol. Immunol. 263: 7-27.
24. Nguyen, K. B., T. P. Salazar-Mather, M. Y. Dalod, J. B. Van Deusen, X. Q. Wei, F. Y. Liew, M. A. Caligiuri, J. E. Durbin, and C. A. Biron. 2002. Coordinated and distinct roles for IFN-αβ, IL-12, and IL-15 regulation of NK cell responses to viral infection. J. Immunol. 169: 4279-4287.
25. Welsh, R. M., Jr., and R. M. Zinkernagel. 1977. Heterospecific cytotoxic cell activity induced during the first three days of acute lymphocytic choriomeningitis virus infection in mice. Nature 268: 646-648.
26. Macfarlan, R. I., W. H. Burns, and D. O. White. 1977. Two cytotoxic cells in peritoneal cavity of virus-infected mice: antibody-dependent macrophages and nonspecific killer cells. J. Immunol. 119: 1569-1574.
27. Huber, S. A., L. P. Job, K. R. Auld, and J. F. Woodruff. 1981. Sex-related differences in the rapid production of cytotoxic spleen cells active against uninfected myofibers during Coxsackievirus B-3 infection. J. Immunol. 126: 1336-1340.
28. Quinnan, G. V., and J. E. Manischewitz. 1979. The role of natural killer cells and antibody-dependent cell-mediated cytotoxicity during murine cytomegalovirus infection. J. Exp. Med. 150: 1549-1554.
29. Kiessling, R. W., and R. M. Welsh, Jr. 1980. Killing of normal cells by activated mouse natural killer cells: evidence for two patterns of genetic regulation of lysis. Int. J. Cancer 25: 611-615.
30. Biron, C. A., S. Habu, K. Okumura, and R. M. Welsh. 1984. Lysis of uninfected and virus-infected cells in vivo: a rejection mechanism in addition to that mediated by natural killer cells. J. Virol. 50: 698-707.
31. Talmadge, J. E., K. M. Meyers, D. J. Prieur, and J. R. Starkey. 1980. Role of natural killer cells in tumor growth and metastasis: C57BL/6 normal and beige mice. J. Natl. Cancer Inst. 65: 929-935.
32. Gresser, I., C. Maury, and D. Brouty-Boye. 1972. Mechanism of the antitumour effect of interferon in mice. Nature 239: 167-168.
33. Brehm, M. A., T. G. Markees, K. A. Daniels, D. L. Greiner, A. A. Rossini, and R. M. Welsh. 2003. Direct visualization of cross-reactive effector and memory allo-specific CD8 T cells generated in response to viral infections. J. Immunol. 170: 4077-4086.
34. Burrows, S. R., R. Khanna, J. M. Burrows, and D. J. Moss. 1994. An alloresponse in humans is dominated by cytotoxic T lymphocytes (CTL) cross-reactive with a single Epstein-Barr virus CTL epitope: implications for graft-versus-host disease. J. Exp. Med. 179: 1155-1161.
35. Braciale, T. J., M. E. Andrew, and V. L. Braciale. 1981. Simultaneous expression of H-2-restricted and alloreactive recognition by a cloned line of influenza virus-specific cytotoxic T lymphocytes. J. Exp. Med. 153: 1371-1376.
36. Kb-restricted anti-vesicular stomatitus virus and alloreactive cytotoxic T cells. J. Immunol. 138: 3654-3660.
37. Adams, A. B., M. A. Williams, T. R. Jones, N. Shirasugi, M. M. Durham, S. M. Kaech, E. J. Wherry, T. Onami, J. G. Lanier, K. E. Kokko, et al. 2003. Heterologous immunity provides a potent barrier to transplantation tolerance. J. Clin. Invest. 111: 1887-1895.
38. Murphy, W. J., C. Y. Koh, A. Raziuddin, M. Bennett, and D. L. Longo. 2001. Immunobiology of natural killer cells and bone marrow transplantation: merging of basic and preclinical studies. Immunol. Rev. 181: 279-289.
39. Oehen, S., K. Brduscha-Riem, A. Oxenius, and B. Odermatt. 1997. A simple method for evaluating the rejection of grafted spleen cells by flow cytometry and tracing adoptively transferred cells by light microscopy. J. Immunol. Methods 207: 33-42.
40. Oberg, L., S. Johansson, J. Michaelsson, E. Tomasello, E. Vivier, K. Karre, and P. Hoglund. 2004. Loss or mismatch of MHC class I is sufficient to trigger NK cell-mediated rejection of resting lymphocytes in vivo: role of KARAP/DAP12-dependent and -independent pathways. Eur. J. Immunol. 34: 1646-1653.
41. Barber, D. L., E. J. Wherry, and R. Ahmed. 2003. Cutting edge: rapid in vivo killing by memory CD8 T cells. J. Immunol. 171: 27-31.
42. Welsh, R. M., P. L. Dundon, E. E. Eynon, J. O. Brubaker, G. C. Koo, and C. L. O'Donnell. 1990. Demonstration of the antiviral role of natural killer cells in vivo with a natural killer cell-specific monoclonal antibody (NK 1.1). Nat. Immun. Cell Growth Regul. 9: 112-120.
43. Daniels, K. A., G. Devora, W. C. Lai, C. L. O'Donnell, M. Bennett, and R. M. Welsh. 2001. Murine cytomegalovirus is regulated by a discrete subset of natural killer cells reactive with monoclonal antibody to Ly49H. J. Exp. Med. 194: 29-44.
44. Mason, L. H., S. K. Anderson, W. M. Yokoyama, H. R. Smith, R. Winkler-Pickett, and J. R. Ortaldo. 1996. The Ly-49D receptor activates murine natural killer cells. J. Exp. Med. 184: 2119-2128.
45. b bone marrow allografts in mice. Int. Immunol. 8: 1833-1839.
46. Selin, L. K., S. R. Nahill, and R. M. Welsh. 1994. Cross-reactivities in memory cytotoxic T lymphocyte recognition of heterologous viruses. J. Exp. Med. 179: 1933-1943.
47. Sentman, C. L., J. Hackett, Jr., V. Kumar, and M. Bennett. 1989. Identification of a subset of murine natural killer cells that mediates rejection of Hh-1d but not Hh-1b bone marrow grafts. J. Exp. Med. 170: 191-202.
48. Raziuddin, A., D. L. Longo, L. Mason, J. R. Ortaldo, M. Bennett, and W. J. Murphy. 1998. Differential effects of the rejection of bone marrow allografts by the depletion of activating versus inhibiting Ly-49 natural killer cell subsets. J. Immunol. 160: 87-94.
49. Mason, L. H., J. R. Ortaldo, H. A. Young, V. Kumar, M. Bennett, and S. K. Anderson. 1995. Cloning and functional characteristics of murine large granular lymphocyte-1: a member of the Ly-49 gene family (Ly-49G2). J. Exp. Med. 182: 293-303.
50. Raziuddin, A., D. L. Longo, M. Bennett, R. Winkler-Pickett, J. R. Ortaldo, and W. J. Murphy. 2002. Increased bone marrow allograft rejection by depletion of NK cells expressing inhibitory Ly49 NK receptors for donor class I antigens. Blood 100: 3026-3033.
51. + T cells. J. Immunol. 154: 2568-2577.
52. Djeu, J. Y., J. A. Heinbaugh, H. T. Holden, and R. B. Herberman. 1979. Augmentation of mouse natural killer cell activity by interferon and interferon inducers. J. Immunol. 122: 175-181.
53. Biron, C. A., G. Sonnenfeld, and R. M. Welsh. 1984. Interferon induces natural killer cell blastogenesis in vivo. J. Leukocyte Biol. 35: 31-37.
54. Murali-Krishna, K., J. D. Altman, M. Suresh, D. J. Sourdive, A. J. Zajac, J. D. Miller, J. Slansky, and R. Ahmed. 1998. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 8: 177-187.
55. Pantenburg, B., F. Heinzel, L. Das, P. S. Heeger, and A. Valujskikh. 2002. T cells primed by leishmania major infection cross-react with alloantigens and alter the course of allograft rejection. J. Immunol. 169: 3686-3693.
56. Williams, M. A., J. T. Tan, A. B. Adams, M. M. Durham, N. Shirasugi, J. K. Whitmire, L. E. Harrington, R. Ahmed, T. C. Pearson, and C. P. Larsen. 2001. Characterization of virus-mediated inhibition of mixed chimerism and allospecific tolerance. J. Immunol. 167: 4987-4995.
57. + T cells and NK cells in irradiated mice. J. Immunol. 155: 3742-3749.
58. Yang, H. Y., P. L. Dundon, S. R. Nahill, and R. M. Welsh. 1989. Virus-induced polyclonal cytotoxic T lymphocyte stimulation. J. Immunol. 142: 1710-1718.
59. Selin, L. K., M. Cornberg, M. A. Brehm, S. K. Kim, C. Calcagno, D. Ghersi, R. Puzone, F. Celada, and R. M. Welsh. 2004. CD8 memory T cells: cross-reactivity and heterologous immunity. Semin. Immunol. 16: 335-347.
60. Diefenbach, A., E. R. Jensen, A. M. Jamieson, and D. H. Raulet. 2001. Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity. Nature 413: 165-171.
61. Cerwenka, A., J. L. Baron, and L. L. Lanier. 2001. Ectopic expression of retinoic acid early inducible-I gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo. Proc. Natl. Acad. Sci. USA 98: 11521-115216.
62. Jamieson, A. M., A. Diefenbach, C. W. McMahon, N. Xiong, J. R. Carlyle, and D. H. Raulet. 2002. The role of the NKG2D immunoreceptor in immune cell activation and natural killing. [Published erratum appears in 2004 Immunity 20: 799.] Immunity 17: 19-29.